Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 1, 2008, Pages

  Davoine, Francis ^a   Cao, Min ^a   Wu, Yingqi ^a   Ajamian, Farnam ^a   Ilarraza, Ramses ^a   Kokaji, Andy I ^a   Moqbel, Redwan ^a   Adamko, Darryl J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

asthma exacerbation; dendritic cell; Eosinophil; eosinophil peroxidase; leukotriene; macrophage; T cell; virus infection

Indexed keywords

CD45RO ANTIGEN; CYTOKINE; EOSINOPHIL PEROXIDASE; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MEDIATOR RELEASE; NONHUMAN; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; VIRUS INACTIVATION;

EID: 46049104167     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.03.028     Document Type: Article

References (53)

1. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 (1995) 1225-1229
2. Nicholson K.G., Kent J., and Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 307 (1993) 982-986
3. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., Runnerstrom E., Sandstrom T., Svensson K., et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164 (2001) 1392-1397
4. Heymann P.W., Carper H.T., Murphy D.D., Platts-Mills T.A., Patrie J., McLaughlin A.P., et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 114 (2004) 239-247
5. Murray C.S., Poletti G., Kebadze T., Morris J., Woodcock A., Johnston S.L., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61 (2006) 376-382
6. Frigas E., and Gleich G.J. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 77 (1986) 527-537
7. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
8. Hargreave F.E. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol 7 (2007) 102-106
9. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
10. Barnes P.J. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 102 (1998) 531-538
11. Rowe B.H., Spooner C.H., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev (2007) CD000195
12. Meagher L.C., Cousin J.M., Seckl J.R., and Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156 (1996) 4422-4428
13. Sivertson K.L., Seeds M.C., Long D.L., Peachman K.K., and Bass D.A. The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils. Cell Immunol 246 (2007) 34-45
14. Yamaya M., and Sasaki H. Rhinovirus and asthma. Viral Immunol 16 (2003) 99-109
15. Ada G.L., and Jones P.D. The immune response to influenza infection. Curr Top Microbiol Immunol 128 (1986) 1-54
16. van Elden L.J., Sachs A.P., van Loon A.M., Haarman M., van de Vijver D.A., Kimman T.G., et al. Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. J Clin Virol 41 (2008) 116-121
17. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359 (2002) 831-834
18. Calhoun W.J., Dick E.C., Schwartz L.B., and Busse W.W. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 94 (1994) 2200-2208
19. Grunberg K., Smits H.H., Timmers M.C., de Klerk E.P., Dolhain R.J., Dick E.C., et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 156 (1997) 609-616
20. Bardin P.G., Fraenkel D., Sanderson G., Dorward M., Johnston S., and Holgate S. Increased sensitivity to the consequences of rhinoviral infection in atopic subjects. Chest 107 suppl (1995) 157S
21. de Kluijver J., Grunberg K., Sont J.K., Hoogeveen M., van Schadewijk W.A., de Klerk E.P., et al. Rhinovirus infection in nonasthmatic subjects: effects on intrapulmonary airways. Eur Respir J 20 (2002) 274-279
22. Baker D.G., Don H.F., and Brown J.K. Direct measurement of acetylcholine release in guinea pig trachea. Am J Physiol Lung Cell Mol Physiol 263 (1992) L142-L147
23. Adamko D.J., Yost B.L., Gleich G.J., Fryer A.D., and Jacoby D.B. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction, and antiviral effects. J Exp Med 190 (1999) 1465-1478
24. Adamko D., Odemuyiwa S.O., and Moqbel R. The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning?. Curr Opin Pharmacol 3 (2003) 227-232
25. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Hamelmann E., and Gelfand E.W. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 162 (1999) 4207-4211
26. Adamko D.J., Wu Y., Gleich G.J., Lacy M.P., and Moqbel R. The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. J Immunol Methods 291 (2004) 101-108
27. Gern J.E., Dick E.C., Lee W.M., Murray S., Meyer K., Handzel Z.T., et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 156 (1996) 621-627
28. Adamko D.J., Wu Y., Ajamian F., Ilarraza R., Moqbel R., and Gleich G.J. The effect of cationic charge on release of eosinophil mediators. J Allergy Clin Immunol (2008) May 1 [epub ahead of print]
29. Fischer S.A., Graham M.B., Kuehnert M.J., Kotton C.N., Srinivasan A., Marty F.M., et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354 (2006) 2235-2249
30. Emonet S., Retornaz K., Gonzalez J.P., de Lamballerie X., and Charrel R.N. Mouse-to-human transmission of variant lymphocytic choriomeningitis virus. Emerg Infect Dis 13 (2007) 472-475
31. Jamieson D.J., Kourtis A.P., Bell M., and Rasmussen S.A. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen?. Am J Obstet Gynecol 194 (2006) 1532-1536
32. Glezen W.P., Frank A.L., Taber L.H., and Kasel J.A. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 150 (1984) 851-857
33. Glezen W.P., Taber L.H., Frank A.L., and Kasel J.A. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140 (1986) 543-546
34. Cox R.J., Brokstad K.A., and Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59 (2004) 1-15
35. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
36. Davoine F., Labonte I., Ferland C., Mazer B., Chakir J., and Laviolette M. Role and modulation of CD16 expression on eosinophils by cytokines and immune complexes. Int Arch Allergy Immunol 134 (2004) 165-172
37. Lacy P., Mahmudi-Azer S., Bablitz B., Hagen S.C., Velazquez J.R., Man S.F., et al. Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. Blood 94 (1999) 23-32
38. Lee Y.M., Miyahara N., Takeda K., Prpich J., Oh A., Balhorn A., et al. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med 177 (2008) 208-218
39. Roberts Jr. N.J. Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages. Infect Immun 35 (1982) 1142-1146
40. Stockl J., Vetr H., Majdic O., Zlabinger G., Kuechler E., and Knapp W. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest 104 (1999) 957-965
41. Guerrero-Plata A., Casola A., Suarez G., Yu X., Spetch L., Peeples M.E., et al. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34 (2006) 320-329
42. Woodhead V.E., Stonehouse T.J., Binks M.H., Speidel K., Fox D.A., Gaya A., et al. Novel molecular mechanisms of dendritic cell-induced T cell activation. Int Immunol 12 (2000) 1051-1061
43. Granoff A., and Webster R.G. (1999), Academic Press, Encyclopedia of Virology
44. Johnston S.L. Natural and experimental rhinovirus infections of the lower respiratory tract. Am J Respir Crit Care Med 152 suppl (1995) S46-S52
45. Korppi M., Kotaniemi-Syrjanen A., Waris M., Vainionpaa R., and Reijonen T.M. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 23 (2004) 995-999
46. Welliver R.C. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection. Semin Perinatol 22 (1998) 87-95
47. Winther B., Gwaltney J.M., and Hendley J.O. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 141 (1990) 839-845
48. Andreoletti L., Lesay M., Deschildre A., Lambert V., Dewilde A., and Wattre P. Differential detection of rhinoviruses and enteroviruses RNA sequences associated with classical immunofluorescence assay detection of respiratory virus antigens in nasopharyngeal swabs from infants with bronchiolitis. J Med Virol 61 (2000) 341-346
49. Mansbach J.M., McAdam A.J., Clark S., Hain P.D., Flood R.G., Acholonu U., et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 15 (2008) 111-118
50. Carlsen K.H., Orstavik I., and Halvorsen K. Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90 months' period. Acta Paediatr Scand 72 (1983) 53-58
51. Gibson P.G., Saltos N., and Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J Allergy Clin Immunol 105 (2000) 752-759
52. Costello R.W., Schofield B.H., Kephart G.M., Gleich G.J., Jacoby D.B., and Fryer A.D. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol Lung Cell Mol Physiol 273 (1997) L93-L103
53. Adamko D.J., Fryer A.D., Bochner B.S., and Jacoby D.B. CD8+ T-lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. Am J Respir Crit Care Med 167 (2003) 550-556